^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SHR-A1307

i
Other names: SHR-A1307
News
Trials
Company:
Jiangsu Hengrui Pharma
Drug class:
EGFR-targeted antibody-drug conjugate
News
Trials